Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. APGE
APGE logo

APGE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

APGE News

Regulatory Approvals and Collaborations in Biotech Sector

1d agoNASDAQ.COM

Wedbush Raises Apogee Therapeutics Price Target to $135 Amid Positive Trial Results

3d agoNASDAQ.COM

Apogee Secures $1.3B Financing to Advance Skin Therapy

3d agoseekingalpha

Apogee Therapeutics Reports Positive Phase 2 APEX Trial Data for Zumilokibart

3d agoNASDAQ.COM

Apogee Therapeutics Secures Up to $1.3 Billion Financing Partnership with Blackstone

3d agoNASDAQ.COM

Apogee Therapeutics Partners with Blackstone for $1.3B Financing

3d agoseekingalpha

Apogee Secures Up to $1.3 Billion in Financing for Zumilokibart Development

3d agoNewsfilter

Analysis of XBI ETF's 52-Week Price Fluctuations

Mar 30 2026NASDAQ.COM

Apogee Therapeutics CEO Sells 20,000 Shares of Stock

Mar 26 2026Fool

Apogee Therapeutics Prices Public Offering at $70 per Share

Mar 25 2026Newsfilter

Apogee Therapeutics Prices Upsized Public Offering of 5M Shares

Mar 25 2026seekingalpha

Apogee Therapeutics Successfully Prices Public Offering

Mar 25 2026Yahoo Finance

Apogee Therapeutics Launches $300 Million Public Offering

Mar 24 2026NASDAQ.COM

US Stocks Surge as Oil Prices Plunge Over 10%

Mar 23 2026NASDAQ.COM

Apogee Therapeutics Launches $300 Million Public Offering

Mar 23 2026seekingalpha

Oil Price Plunge Boosts Stock Market Gains

Mar 23 2026NASDAQ.COM